Armata Pharmaceuticals, Inc. (ARMP) Financials
ARMP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 120.4 million | 176.9 million |
| 2023-12-31 | 110.0 million | 142.0 million |
| 2023-09-30 | 112.8 million | 125.1 million |
| 2023-06-30 | 101.2 million | 82.1 million |
ARMP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -10.8 million | 534000 |
| 2023-12-31 | -10.5 million | 193000 |
| 2023-09-30 | -13.2 million | -373000 |
| 2023-06-30 | -12.3 million | 261000 |
ARMP Net Income
No data available :(
ARMP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 37.9 million | - | 35.9 million |
| 2023-12-31 | 13.5 million | - | 38.1 million |
| 2023-09-30 | 24.0 million | - | 41.6 million |
| 2023-06-30 | 12.5 million | - | 42.0 million |
ARMP Shares Outstanding
ARMP Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 250000 | 8.0 million | 3.2 million | 317000 |
| 2023-12-31 | 2.4 million | 7.9 million | 3.2 million | 293000 |
| 2023-09-30 | 3.5 million | 8.0 million | 3.6 million | - |
| 2023-06-30 | 222000 | 8.3 million | 2.4 million | - |
ARMP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 966000 | 317000 |
| 2023-12-31 | 1.5 million | 293000 |
| 2023-09-30 | 1.2 million | 221000 |
| 2023-06-30 | 980000 | 200000 |
ARMP
Price: $2.59
52 week price:
Earnings Per Share: -1.88 USD
P/E Ratio: -2.02
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 6136
Market Capitalization: 116.1 million